Personalized Medicine News and Research

RSS

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

Veterans Affairs researchers have found that certain forms, or alleles, of a gene known to play a key role in the immune system appear to offer protection from Gulf War illness (GWI). Further, they discovered how such protection is manifested in the brain.

17 Nov 2016

Technion researchers develop new diagnostic technology for improving personalized cancer treatment

Using synthetic DNA sequences as the tiniest of barcodes, Technion researchers have developed a new diagnostic technology for determining the suitability of specific anticancer drugs to a specific patient - before treatment even begins.

11 Nov 2016

Personalized medicine may offer solution for treatment of psychiatric disturbances

An ever widening gap is appearing between clinical practice and the treatment prescribed in DSM-5, the standard work on schizophrenia, psychiatrist Jan Dirk Blom will assert in his inaugural lecture on 11 November.

11 Nov 2016

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.

10 Nov 2016

ASH partners with other organizations to address knowledge gaps in AML care

The American Society of Hematology has partnered with several organizations on independent educational programming designed to help address knowledge gaps in the diagnosis and treatment of acute myeloid leukemia (AML).

8 Nov 2016

Scientists use latest sequencing technology to review genetic makeup of ataxias syndrome

According to a recent study published in JAMA Neurology, Northwestern Medicine scientists have examined more than a century of data of the genetic makeup of ataxias, a neurodegenerative disorder, to better understand the different forms of this devastating disease and how it affects patients.

8 Nov 2016

Study explores biological marker to predict individual response to drug treatment for combat PTSD

Treatment with the drug prazosin effectively reduces symptoms of posttraumatic stress disorder (PTSD) for many people, but about one third of patients don't respond to the treatment at all.

5 Nov 2016

Brain plasticity after injury: an interview with Dr Swathi Kiran

Brain plasticity is the phenomenon by which the brain can rewire and reorganize itself in response to changing stimulus input. Brain plasticity is at play when one is learning new information (at school) or learning a new language...

3 Nov 2016

Illumina donates more than 95,000 human genetic variants to ClinVar database

Illumina, Inc. announced that it has contributed over 95,000 human genetic variants to ClinVar, a public database hosted by the National Center for Biotechnology Information (NCBI).

From Illumina, Inc. 1 Nov 2016

Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced it will present two new studies at the American Society of Dermatopathology (ASDP) annual meeting being held Oct. 27-30, 2016 in Chicago, Ill.

31 Oct 2016

Scientists pinpoint the brain region responsible for ‘placebo effect’ in pain relief

Scientists have identified for the first time the region in the brain responsible for the "placebo effect" in pain relief, when a fake treatment actually results in substantial reduction of pain, according to new research from Northwestern Medicine and the Rehabilitation Institute of Chicago.

27 Oct 2016

Myriad Genetics and ION Solutions partner to provide accurate, comprehensive hereditary cancer tests

Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing in the support of community oncology, announced today that they have entered into a relationship to deliver quality hereditary cancer test results and services to ION member practices.

24 Oct 2016

Targeting TASINs can be viable approach for preventing colon cancer, research reveals

A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated.

20 Oct 2016

Scientists use 3-D printing to develop customized biodegradable stents

Most people have heard about personalized medicine. But how about personalized medical devices? Northwestern Engineering's Guillermo Ameer and Cheng Sun have teamed up to use 3-D printing to develop flexible, biodegradable stents that are customized for a specific patient's body.

12 Oct 2016

Behavioral activation as effective as CBT? An interview with Professor David Richards

BA and CBT are quite fundamentally different. BA is what we call an outside-in treatment, which means it focuses on helping people with depression change the way in which they behave.

10 Oct 2016

First-ever neuroscience conference to explore ultra-personal approach to brain health

For three days this week, Roanoke, Virginia, is the capital of the precision neuroscience world.

7 Oct 2016

Mayo Clinic recommends four ways physicians can use individualized medicine to treat patients

Individualized medicine is no longer the lore of science fiction. It is offering new hope for patients with cancer, heart disease, depression and rare diseases for which there historically have been no diagnosis or treatment. And that's just the beginning.

5 Oct 2016

Study opens door towards personalized medicine for children with eczema

Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.

5 Oct 2016

Are migraines genetic? An interview with Nick Furlotte

There's a big debate right now in the migraine community around the underlying cause of the disease. The question is whether it is vascular, and has something to do with our vessels, or whether it has to do with our neurons not functioning correctly or misfiring.

26 Sep 2016

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Personalized Medicine News and Research

Veterans Affairs researchers discover alleles of certain genes that offer protection from GWI

Technion researchers develop new diagnostic technology for improving personalized cancer treatment

Personalized medicine may offer solution for treatment of psychiatric disturbances

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

ASH partners with other organizations to address knowledge gaps in AML care

Scientists use latest sequencing technology to review genetic makeup of ataxias syndrome

Study explores biological marker to predict individual response to drug treatment for combat PTSD

Brain plasticity after injury: an interview with Dr Swathi Kiran

Illumina donates more than 95,000 human genetic variants to ClinVar database

Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Scientists pinpoint the brain region responsible for ‘placebo effect’ in pain relief

Myriad Genetics and ION Solutions partner to provide accurate, comprehensive hereditary cancer tests

Targeting TASINs can be viable approach for preventing colon cancer, research reveals

Scientists use 3-D printing to develop customized biodegradable stents

Behavioral activation as effective as CBT? An interview with Professor David Richards

First-ever neuroscience conference to explore ultra-personal approach to brain health

Mayo Clinic recommends four ways physicians can use individualized medicine to treat patients

Study opens door towards personalized medicine for children with eczema

Are migraines genetic? An interview with Nick Furlotte

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News